Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 206

The DOI matches its Crossref record.

Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen

Open access
Quinn, Conrad P., Semenova, Vera A., Elie, Cheryl M., Romero-Steiner, Sandra, Greene, Carolyn, Li, Han, Stamey, Karen, Steward-Clark, Evelene, Schmidt, Daniel S., Mothershed, Elizabeth, Pruckler, Janet, Schwartz, Stephanie, Benson, Robert F., Helsel, Leta O., Holder, Patricia F., Johnson, Scott E., Kellum, Molly, Messmer, Trudy, Thacker, W. Lanier, Besser, Lilah, Plikaytis, Brian D., Taylor, Thomas H., Freeman, Alison E., Wallace, Kelly J., Dull, Peter, Sejvar, Jim, Bruce, Erica, Moreno, Rosa, Schuchat, Anne, Lingappa, Jairam R., Martin, Sandra K., Walls, John, Bronsdon, Melinda, Carlone, George M., Bajani-Ari, Mary, Ashford, David A., Stephens, David S., Perkins, Bradley A. · 2002 · Emerging Infectious Diseases

Abstract

The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted the need for a sensitive, reproducible, and specific laboratory test for the confirmatory diagnosis of human anthrax. The Centers for Disease Control and Prevention developed, optimized, and rapidly qualified an enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G (IgG) antibodies to Bacillus anthracis protective antigen (PA) in human serum. The qualified ELISA had a minimum detection limit of 0.06 micro g/mL, a reliable lower limit of detection of 0.09 micro g/mL, and a lower limit of quantification in undiluted serum specimens of 3.0 micro g/mL anti-PA IgG. The diagnostic sensitivity of the assay was 97.8%, and the diagnostic specificity was 97.6%. A competitive inhibition anti-PA IgG ELISA was also developed to enhance diagnostic specificity to 100%. The anti-PA ELISAs proved valuable for the confirmation of cases of cutaneous and inhalational anthrax and evaluation of patients in whom the diagnosis of anthrax was being considered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid0810.020380

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 206

Metadata

Authors
Quinn, C. P., Semenova, V. A., Elie, C. M., Romero-Steiner, S., Greene, C., Li, H., Stamey, K., Steward-Clark, E., Schmidt, D. S., Mothershed, E., Pruckler, J., Schwartz, S., Benson, R. F., Helsel, L. O., Holder, P. F., Johnson, S. E., Kellum, M., Messmer, T., Thacker, W. L., Besser, L., Plikaytis, B. D., Taylor, T. H., Freeman, A. E., Wallace, K. J., Dull, P., Sejvar, J., Bruce, E., Moreno, R., Schuchat, A., Lingappa, J. R., Martin, S. K., Walls, J., Bronsdon, M., Carlone, G. M., Bajani-Ari, M., Ashford, D. A., Stephens, D. S., & Perkins, B. A.
Venue
Emerging Infectious Diseases
Published
2002-10
Volume
8
Issue
10
Pages
1103-1110
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2112861955
Cited by
206
References
0
FWCI
3.02
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen. https://app.cochat.ai/papers/10.3201/eid0810.020380
The paper
Quinn, C. P., Semenova, V. A., Elie, C. M., Romero-Steiner, S., Greene, C., Li, H., Stamey, K., Steward-Clark, E., Schmidt, D. S., Mothershed, E., Pruckler, J., Schwartz, S., Benson, R. F., Helsel, L. O., Holder, P. F., Johnson, S. E., Kellum, M., Messmer, T., Thacker, W. L., . . . Perkins, B. A. (2002). Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen. Emerging Infectious Diseases. https://doi.org/10.3201/eid0810.020380

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.